Compare UPC & RENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UPC | RENX |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.0M |
| IPO Year | 2021 | N/A |
| Metric | UPC | RENX |
|---|---|---|
| Price | $4.16 | $0.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 203.5K | ★ 17.5M |
| Earning Date | 04-29-2025 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,293,003.00 | $4,970,752.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2770.15 |
| 52 Week Low | $2.51 | $0.16 |
| 52 Week High | $24.74 | $2.74 |
| Indicator | UPC | RENX |
|---|---|---|
| Relative Strength Index (RSI) | 50.69 | N/A |
| Support Level | $3.84 | N/A |
| Resistance Level | $4.55 | N/A |
| Average True Range (ATR) | 0.58 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 13.43 | 0.00 |
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
RenX Enterprises Corp is a real estate development and environmental solutions company. It is focused on the direct acquisition and indirect investment in properties across the United States that are intended for development into green single-family or multifamily housing projects. The company also focuses on the monetization of its real estate assets. It processes source-separated green waste and is expanding into the production of sustainable, high-margin potting media and soil substrates through advanced milling technology.